Cargando…
Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia
Despite significant progress over the last few decades in the treatment of acute myeloid leukemia (AML), there still remains a major unmet medical need for this disease. Immunotherapy approaches for redirecting pan CD3(+) T cells to target leukemia blasts have shown limited efficacy in clinical tria...
Autores principales: | Ganesan, Rajkumar, Chennupati, Vijaykumar, Ramachandran, Balaji, Hansen, Michael Riis, Singh, Sanjaya, Grewal, Iqbal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324575/ https://www.ncbi.nlm.nih.gov/pubmed/33526858 http://dx.doi.org/10.1038/s41375-021-01122-7 |
Ejemplares similares
-
Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform
por: Borrok, M. Jack, et al.
Publicado: (2022) -
Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017) -
Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017) -
Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia
por: Kubicka, Ewa, et al.
Publicado: (2022) -
Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)